We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Medical Equipment Donated to Haiti Disaster Relief

By LabMedica International staff writers
Posted on 17 Feb 2010
Immediately following the January 12, 2010, earthquake, Siemens Healthcare (Erlangen, Germany) mobilized to provide disaster relief assistance to the citizens of Haiti. More...
The Healthcare Sector of Siemens AG has shipped healthcare systems and supplies through Project HOPE (Millwood, VA, USA) to aid healthcare workers in their efforts to help the victims.

Siemens Healthcare has donated 20 Acuson P10 ultrasound systems. These handheld systems are well suited for the urgent medical needs in Haiti as they were designed for triage and emergency situations and provide physicians and emergency personnel with earlier, faster, and more accurate clinical assessment in seconds. The system provides Focused Abdominal Sonography for Trauma (FAST) protocols, which can identify free fluid from organ ruptures due to blunt trauma and identify foreign objects lodged inside the body. The unit runs on battery power, and will scan continuously for one hour with one charge. An average scan in disaster type conditions only takes minutes. Because of its pocket-sized design and lightweight of only 0.73 kg, the Acuson P10 system is especially useful in the cramped and difficult working conditions in Haiti.

Siemens donated 10 RAPIDPoint 350 blood gas analyzers to Project HOPE. These systems can be used to provide critical care blood gas and blood electrolyte-test results within minutes in a field hospital setting. With these blood gas analyzers, Siemens provided sufficient test systems and supplies to perform 90,000 tests and worked with their partner, Smiths Medical (London, UK), who also donated sterile blood sample syringes necessary to perform the tests.

Moreover, Siemens donated enough Multistix 10 SG urinalysis strips to perform 90,000 urine tests. These test strips assist rapid diagnosis in kidney function, urinary tract infections, carbohydrate metabolism, and liver function.

The Siemens technical team will be available by telephone to support Project HOPE as needed in the set up and operation of the systems.

The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology, and hearing aids.

Founded in 1958, Project HOPE (Health Opportunities for People Everywhere) is dedicated to providing lasting solutions to health problems with the mission of helping people to help themselves. Identifiable to many by the SS HOPE, the world's first peacetime hospital ship, Project HOPE now provides medical training and health education, as well as conducts humanitarian assistance programs in more than 35 countries.

Related Links:

Siemens Healthcare
Project HOPE



New
Gold Member
Aspiration System
VACUSAFE
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Clinical Informatics Platform
CLARION™
New
Total Laboratory Automation Solution
SATLARS Mini T8
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Accurate immunotherapy selection for esophageal and GEJ carcinomas depends on consistent PD-L1 assessment (credit: Adobe Stock)

FDA Approval Expands Use of PD-L1 Companion Diagnostic in Esophageal and GEJ Carcinomas

Esophageal and gastroesophageal junction carcinomas (GEJ) have a poor prognosis, with approximately 16,250 deaths in the United States in 2025 and a five-year relative survival of 21.9%.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.